Login / Signup

High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection.

Matheus Silva AlvesMarilha da Silva CariolanoHivylla Lorrana Dos Santos FerreiraElen Sousa de Abreu SilvaKaren Karollynny Pereira FelipeSilvio Gomes MonteiroEduardo Martins de SousaAfonso Gomes AbreuLee Ann CampbellMichael E RosenfeldMario Hiroyuki HirataRosario Dominguez Crespo HirataGisele Medeiros BastosIlana Cristina de Paula Abreu SilvaLidio Gonçalves Lima-Neto
Published in: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (2020)
This study was performed as a contribution for a better understanding of Chlamydia pneumoniae frequency in children with respiratory infections. A total of 416 children were recruited from two clinical centers in Sao Luis, Brazil. Of these patients, 165 children had upper respiratory tract infections (URTI), 150 had community-acquired pneumonia (CAP), and 101 were asymptomatic volunteer children. Clinical and epidemiological data from the participants were recorded. Nasopharyngeal swab samples were collected to extract DNA. C. pneumoniae DNA positivity and copy numbers were obtained by an absolute quantitative real-time PCR method. RESULTS: Positivity for C. pneumoniae DNA was higher in samples from URTI children (38.2%) and from CAP children (18.0%) than in those from the control group (7.9%; p < 0.001). Moreover, C. pneumoniae DNA was denser in children with URTI than in asymptomatic children. Considering the cutoff, the highest value of C. pneumoniae DNA found in asymptomatic children of the 3.98 log10 copies/mL, 8.5% (14/165) of the children with URTI, and 3.3% (5/150) with CAP presented high copy numbers of C. pneumoniae DNA. CONCLUSION: Taken together, these results revealed a high frequency of C. pneumoniae in both children with URTI and CAP.
Keyphrases
  • young adults
  • high frequency
  • respiratory tract
  • risk factors
  • circulating tumor
  • oxidative stress
  • mass spectrometry
  • newly diagnosed
  • end stage renal disease
  • electronic health record
  • patient reported outcomes